XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2020 $ 11,061 $ 57 $ 27,443 $ (10,946) $ (2,399) $ (4,128) $ 10,026 $ 1,035
Beginning balance, shares at Dec. 31, 2020   1,202            
Net Income (loss) 608     576     576 32
Other comprehensive income (loss) (302)       (221)   (221) (81)
Issuance of Shares, shares [1]   7            
Stock-based compensation expense 86   86       86  
Ending balance at Sep. 30, 2021 11,451 $ 57 27,529 (10,370) (2,620) (4,128) 10,467 984
Ending balance, shares at Sep. 30, 2021   1,209            
Beginning balance at Jun. 30, 2021 11,311 $ 57 27,503 (10,662) (2,446) (4,128) 10,324 987
Beginning balance, shares at Jun. 30, 2021   1,209            
Net Income (loss) 302     292     292 11
Other comprehensive income (loss) (187)       (174)   (174) (13)
Stock-based compensation expense 26   26       26  
Ending balance at Sep. 30, 2021 11,451 $ 57 27,529 (10,370) (2,620) (4,128) 10,467 984
Ending balance, shares at Sep. 30, 2021   1,209            
Beginning balance at Dec. 31, 2021 11,244 $ 57 27,561 (10,529) (2,683) (4,128) 10,278 966
Beginning balance, shares at Dec. 31, 2021   1,209            
Net Income (loss) (1,152)     (1,132)     (1,132) (21)
Other comprehensive income (loss) (663)       (470)   (470) (193)
Issuance of Shares, value [1] 1   1       1  
Issuance of Shares, shares [1]   7            
Stock-based compensation expense 88   88       88  
Ending balance at Sep. 30, 2022 9,519 $ 57 27,652 (11,660) (3,153) (4,128) 8,767 751
Ending balance, shares at Sep. 30, 2022   1,216            
Beginning balance at Jun. 30, 2022 9,828 $ 57 27,625 (11,716) (2,801) (4,128) 9,037 791
Beginning balance, shares at Jun. 30, 2022   1,216            
Net Income (loss) 58     56     56 3
Other comprehensive income (loss) (395)       (352)   (352) (43)
Stock-based compensation expense 26   26       26  
Ending balance at Sep. 30, 2022 $ 9,519 $ 57 $ 27,652 $ (11,660) $ (3,153) $ (4,128) $ 8,767 $ 751
Ending balance, shares at Sep. 30, 2022   1,216            
[1] Represents an amount less than $0.5 million.